News & Media

AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care

November 28th, 2023 Press Release

AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its AmacaGel delivery platform, announced the closing of a CAD$4.0 million financing round.Read more

AmacaThera Secures Funding to Initiate Phase I Trial of Non-Opioid Pain Control Therapeutic

January 8th, 2019 Press Release

AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has already raised $3.25 million (CAD) in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners.Read more

Ontario Names Molly Shoichet the Province's First Chief Scientist

November 17th, 2017 Press Release

Shoichet Will Help Accelerate Scientific Innovation and Advance Science in Government Decision-Making.Read more

News & Media

AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care

AmacaThera Secures Funding to Initiate Phase I Trial of Non-Opioid Pain Control Therapeutic

Ontario Names Molly Shoichet the Province's First Chief Scientist

Quarterly updates in your inbox